Position in TRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,223,365
+$335,225 QoQ
Shares Held
65,596
-11.9% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#102
of 216 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SECTORAL ASSET MANAGEMENT INC holds $69,797,747 across 47 Biotechnology names. TRVI ranks #18 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CTNM |
Contineum Therapeutics, Inc.
|
727,587 | $11,925,150 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
41,987 | $3,995,902 | |
| 3 | BNTX |
BioNTech SE
|
41,869 | $3,895,910 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
78,310 | $3,683,702 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
110,870 | $3,418,122 | |
| 6 | SMMT |
Summit Therapeutics Inc.
|
220,180 | $3,208,022 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
|
79,043 | $2,745,953 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,432 | $2,698,237 |
All Filings in TRVI
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,223,365 | 65,596 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $888,140 | 74,446 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,054,872 | 84,255 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $969,442 | 105,950 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $733,800 | 134,150 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $514,522 | 81,800 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||